- Home
- ICCM vs MYND Comparison
ICCM vs MYND Comparison
Compare ICCM & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | MYND |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Other Consumer Services |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 19.2M |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ICCM | MYND |
|---|---|---|
| Price | $3.25 | $0.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 75.6K | 8.1K |
| Earning Date | 05-27-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $139.51 | N/A |
| Revenue Next Year | $75.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.28 |
| 52 Week High | $9.54 | $1.15 |
Technical Indicators
Market Signals| Indicator | ICCM | MYND |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 50.65 |
| Support Level | $0.61 | $0.30 |
| Resistance Level | $5.69 | $0.44 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 70.46 | 71.25 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About MYND Mynd.ai Inc.
Mynd.ai Inc provides world'wide, end-to-end, learning solutions and collaboration tools to help teachers, schools, students, and professionals realize their greatest potential. The company has single reporting segment. The company has presence in United States and Rest of world. The company generates majority of revenue from United States.